Re:Ask HN: What's the best paper you've read in 2020?
by benrapscallion on Tuesday December 08, 2020 @08:31PM
(#25354235)
Small correction: the paper is in Nature Communications and not Nature.
Re:Ask HN: What's the best paper you've read in 2020?
by eurasiantiger on Wednesday December 09, 2020 @09:27AM
(#25358775)
So we could, in principle, selectively demethylate those regions of DNA and cure some cancers?
Re:Ask HN: What's the best paper you've read in 2020?
by yellowcake0 on Wednesday December 09, 2020 @12:59PM
(#25361468)
Cancer isn't caused by abnormal methylation patterns.
The ctDNA are just fragments of DNA which have been shed by the tumor and are now circulating in the blood stream.
Re:Ask HN: What's the best paper you've read in 2020?
by petra on Wednesday December 09, 2020 @01:01AM
(#25355800)
That's great news!
So now after we know that, what are the treatment options at that stage ?
Re:Ask HN: What's the best paper you've read in 2020?
by yellowcake0 on Wednesday December 09, 2020 @02:16AM
(#25356149)
Probably many of the same ones that are used in the later stages.
My understanding is that the prognosis is much better the earlier one begins treatment.
[dead]
Re:Ask HN: What's the best paper you've read in 2020?
by ashudeep on Wednesday December 09, 2020 @02:20AM
(#25356173)
What's with the sugar?
Re:Ask HN: What's the best paper you've read in 2020?
by phobosanomaly on Wednesday December 09, 2020 @02:08AM
(#25356108)
Combine that with the breakthrough in protein folding and mRNA vaccines and we could have a rapid pipeline for custom, targeted immunotherapies for not just new bugs, but new cancers.
Non-invasive early detection of cancer four years before conventional diagnosis using a blood test
https://www.nature.com/articles/s41467-020-17316-z
Major breakthrough in cell-free diagnostics. The methylation pattern of DNA can be used to identify early-stage cancer, i.e. circulating tumor DNA (ctDNA) has a distinct methylation pattern.
The results are based on data from a ten year study which must have cost a fortune to run.